Fowler Brian
Metabolic Unit, University Children's Hospital Basel (UKBB), Basel, Switzerland.
Semin Vasc Med. 2005 May;5(2):77-86. doi: 10.1055/s-2005-872394.
Homocysteine is derived from the essential amino acid methionine and plays a vital role in cellular homeostasis in man. Homocysteine levels depend on its synthesis, involving methionine adenosyltransferase, S-adenosylmethionine-dependent methyltransferases such as glycine N-methyltransferase, and S-adenosylhomocysteine hydrolase; its remethylation to methionine by methionine synthase, which requires methionine synthase reductase, vitamin B (12), and 5-methyltetrahydrofolate produced by methylenetetrahydrofolate reductase or betaine methyltransferase; and its degradation by transsulfuration involving cystathionine beta-synthase. The control of homocysteine metabolism involves changes of tissue content or inherent kinetic properties of the enzymes. In particular, S-adenosylmethionine acts as a switch between remethylation and transsulfuration through its allosteric inhibition of methylenetetrahydrofolate reductase and activation of cystathionine beta-synthase. Mutant alleles of genes for these enzymes can lead to severe loss of function and varying severity of disease. Several defects lead to severe hyperhomocysteinemia, the most common form being cystathionine beta-synthase deficiency, with more than a hundred reported mutations. Less severe elevations of plasma homocysteine are caused by folate and vitamin B (12) deficiency, and renal disease and moderate hyperhomocysteinemia are associated with several common disease states such as cardiovascular disease. Homocysteine toxicity is likely direct or caused by disturbed levels of associated metabolites; for example, methylation reactions through elevated S-adenosylhomocysteine.
同型半胱氨酸源自必需氨基酸甲硫氨酸,在人体细胞内稳态中发挥着至关重要的作用。同型半胱氨酸水平取决于其合成过程,这涉及甲硫氨酸腺苷转移酶、依赖S -腺苷甲硫氨酸的甲基转移酶(如甘氨酸N -甲基转移酶)以及S -腺苷同型半胱氨酸水解酶;它通过甲硫氨酸合酶再甲基化生成甲硫氨酸,此过程需要甲硫氨酸合酶还原酶、维生素B12以及由亚甲基四氢叶酸还原酶或甜菜碱甲基转移酶产生的5 -甲基四氢叶酸;还取决于通过转硫途径降解,该途径涉及胱硫醚β -合酶。同型半胱氨酸代谢的调控涉及组织含量变化或酶的固有动力学特性改变。特别是,S -腺苷甲硫氨酸通过变构抑制亚甲基四氢叶酸还原酶以及激活胱硫醚β -合酶,在再甲基化和转硫途径之间起到开关作用。这些酶的基因突变等位基因可导致严重的功能丧失及不同严重程度的疾病。几种缺陷会导致严重的高同型半胱氨酸血症,最常见的形式是胱硫醚β -合酶缺乏,已报道的突变有一百多种。血浆同型半胱氨酸轻度升高是由叶酸和维生素B12缺乏引起的,而肾脏疾病和中度高同型半胱氨酸血症与几种常见疾病状态(如心血管疾病)相关。同型半胱氨酸毒性可能是直接的,也可能是由相关代谢物水平紊乱导致的;例如,通过升高的S -腺苷同型半胱氨酸进行甲基化反应。